Stock Research for CYTK

CYTK
Current Price

$8.0000


Latest Update: 2018-02-16 16:00:00

High
$ 8.0500
Low
$ 8.0000
Close
$ 8.0250
Volume
20559
 
  

Featured Broker: TradeStation

Get the due diligence for another stock.

 

CYTK Stock Chart & Research Data

The CYTK chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the CYTK chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


CYTK Due diligence Resources & Stock Charts

The CYTK stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View CYTK Detailed Price Forecast - CNN Money CNN View CYTK Detailed Summary - Google Finance
Yahoo View CYTK Detailed Summary - Yahoo! Finance Zacks View CYTK Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View CYTK Trends & Analysis - Trade-Ideas Barrons View CYTK Major Holders - Barrons
NASDAQ View CYTK Call Transcripts - NASDAQ Seeking View CYTK Breaking News & Analysis - Seeking Alpha
Spotlight View CYTK Annual Report - CompanySpotlight.com OTC Report View CYTK OTC Short Report - OTCShortReport.com
TradeKing View CYTK Fundamentals - TradeKing Charts View CYTK SEC Filings - Bar Chart
WSJ View Historical Prices for CYTK - The WSJ Morningstar View Performance/Total Return for CYTK - Morningstar
MarketWatch View the Analyst Estimates for CYTK - MarketWatch CNBC View the Earnings History for CYTK - CNBC
StockMarketWatch View the CYTK Earnings - StockMarketWatch MacroAxis View CYTK Buy or Sell Recommendations - MacroAxis
Bullish View the CYTK Bullish Patterns - American Bulls Short Pains View CYTK Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View CYTK Stock Mentions - StockTwits PennyStocks View CYTK Stock Mentions - PennyStockTweets
Twitter View CYTK Stock Mentions - Twitter Invest Hub View CYTK Investment Forum News - Investor Hub
Yahoo View CYTK Stock Mentions - Yahoo! Message Board Seeking Alpha View CYTK Stock Mentions - Seeking Alpha




Financial & Transaction Holdings

SECform4 View Insider Transactions for CYTK - SECform4.com Insider Cow View Insider Transactions for CYTK - Insider Cow
CNBC View CYTK Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for CYTK - OTC Markets
Yahoo View Insider Transactions for CYTK - Yahoo! Finance NASDAQ View Institutional Holdings for CYTK - NASDAQ


Stock Charts

FinViz View CYTK Stock Insight & Charts - FinViz.com StockCharts View CYTK Investment Charts - StockCharts.com
BarChart View CYTK Stock Overview & Charts - BarChart Trading View View CYTK User Generated Charts - Trading View


Latest Financial News for CYTK

Market Trends Toward New Normal in Tile Shop Holdings, Cytokinetics, Limelight Networks, CatchMark Timber Trust, Global Payments, and Charles River Laboratories International — Emerging Consolidated Expectations, Analyst Ratings
Posted on Friday February 16, 2018

NEW YORK, Feb. 16, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Tile ...


Cytokinetics reports 4Q loss
Posted on Thursday February 15, 2018

On a per-share basis, the South San Francisco, California-based company said it had a loss of 75 cents. The results did not meet Wall Street expectations. The average estimate of four analysts surveyed ...


Cytokinetics, Inc. Reports Fourth Quarter 2017 Financial Results
Posted on Thursday February 15, 2018

Company Provides 2018 Financial Guidance and Expected Milestones; Reduced Operating Expenses vs. 2017; Over Two Years of Cash Based on Current Burn Rate. CK-2127107 Advancing in Four Clinical Trials Under ...


Cytokinetics, Incorporated to Host Earnings Call
Posted on Thursday February 15, 2018

NEW YORK, NY / ACCESSWIRE / February 15, 2018 / Cytokinetics, Incorporated (NASDAQ: CYTK ) will be discussing their earnings results in their Q4 Earnings Call to be held on February 15, 2018 at 4:30 PM ...


Cytokinetics, Inc. Reports Fourth Quarter 2017 Financial Results
GlobeNewswire (press release) - Feb 15, 2018
SOUTH SAN FRANCISCO, Calif., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq:CYTK) reported financial results for the fourth quarter of 2017.
Cytokinetics reports 4Q loss - Citizentribune
Cytokinetics Inc Has Bullish Trade, Biotechnology Value Fund LP Bought Stake! - BZ Weekly

Cytokinetics ALS Drug Fails
Forbes - Nov 21, 2017
Robert Blum, Cytokinetics' chief executive, said in a statement that the company is "deeply disappointed" by the results, and that it will not continue developing the drug, tirasemtiv, despite what he called evidence of "pharmacologic activity for the ...

Cytokinetics, Inc. Reports Third Quarter 2017 Financial Results
GlobeNewswire (press release) - Oct 26, 2017
SOUTH SAN FRANCISCO, Calif., Oct. 26, 2017 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq:CYTK) reported total revenues for the third quarter of 2017 were $6.2 million, compared to $59.0 million, during the same period in 2016.
Cytokinetics (CYTK) CEO Robert Blum on Q3 2017 Results - Earnings Call Transcript - Seeking Alpha

Cytokinetics to Present at the RBC Capital Markets Global Healthcare Conference
GlobeNewswire (press release) - Feb 12, 2018
Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining ...

Enter a stock symbol to view the stock details.